Senseonics Holdings, Inc. (NYSE:SENS) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET
Company Participants
Jeremy Feffer – Investor Relations, LifeSci Advisors
Tim Goodnow – President and Chief Executive Officer
Brian Hansen – President of CGM at Ascensia Diabetes Care
Rick Sullivan – Chief Financial Officer
Conference Call Participants
Mathew Blackman – Stifel
Matt Taylor – Jefferies
Marie Thibault – BTIG
Operator
Good day, everyone, and welcome to today’s Senseonics Fourth Quarter and Full Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. Please note, today’s call will be recorded and I will be standing by should you need any assistance.
It is now my pleasure to turn the conference over to Jeremy Feffer from LifeSci Advisors. Please go ahead.
Jeremy Feffer
Thank you. This is Jeremy Feffer from LifeSci Advisors.
Before we begin today, let me remind you that the company’s remarks include forward-looking statements. These statements reflect management’s expectations about future events, operating plans, regulatory matters, product enhancements, company performance, and other matters and speak only as of the date hereof. These forward-looking statements involve a number of risks and uncertainties.
A list of the factors that could cause actual results to be materially different from those expressed or implied by any of these forward-looking statements is detailed under Risk Factors and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2024, and our other reports filed with the SEC. These documents are available on the Investor Relations section of our website at www.senseonics.com. We undertake no obligation to update publicly or revise these forward-looking statements for any reason except as required by law.
Joining me today from Senseonics are Tim Goodnow, President and
